IPO YEAR:
2021
|
Sector:
Health Care
|
Industry:
Biotechnology: Biological Products (No Diagnostic Substances)
|
ADRTSO:
|
MarketCap:
3029364275.00
|
Beta:
|
52 Week High:
15.86
|
52 Week Low:
7.91
|
52 Week Change:
-0.0958498023715414
|
Short Interest:
|
Short Date:
|
Shares Outstanding:
1310783159
|
Dividend Rate:
0
|
Dividend Yield:
0.00%
|
ExDividend Date:
|
Latest EPS:
|
Latest EPS Date:
9 Nov 2022
|
Float:
0
|
return on Equity:
3.50%
|
Consensus EPS:
|
Number Of Estimates:
|
EPS Surprise Dollar:
|
Eps Surprise Percent:
|
EBITDA:
$12.735B
|
ttmEPS:
0
|
Revenue:
$81.106B
|
Gross Profit:
|
Cash:
|
Debt:
|
Institution Percent:
63.80%
|
Revenue Percent:
|
Revenue Per Employee:
|
Insider Percent:
0.13%
|
Return on Assets:
1.50%
|
Return on Capital:
|
Profit Margin:
3.90%
|
Price to Sales:
2.25
|
Price To Book:
1.92
|
Short Ratio:
1.88
|
PE Ratio:
0
|
Employees:
2021
|
1Y Guesstimate
N/A:N/A:N/A
|
|
|
|
|
|
|
|
|
